LL-37 secreted by epithelium promotes fibroblast collagen production: A potential mechanism of small airway remodeling in chronic obstructive pulmonary disease

Laboratory Investigation

Volumn 94, Issue 9, 2014, Pages 991-1002

  Sun, Congcong ^a   Zhu, Maoxiang ^b   Yang, Zhihua ^b   Pan, Xiujie ^b   Zhang, Yuke ^a   Wang, Qin ^a   Xiao, Wei ^a  

^a SHANDONG UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY REMODELING; AMINO ACID SEQUENCE; ANTIMICROBIAL CATIONIC PEPTIDES; BASE SEQUENCE; CASE-CONTROL STUDIES; CELL LINE; COLLAGEN; DNA PRIMERS; FEMALE; FIBROBLASTS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING;

EID: 84906828437     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.86     Document Type: Article

References (43)

1. Pauwels R. Global initiative for chronic obstructive lung diseases(GOLD): Time to act. Eur Respir J 2001;18:901-902.
2. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airwayobstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355-1360.
3. Shaw RJ, Djukanovic R, Tashkin DP, et al. The role of small airways inlung disease. Respir Med 2002;96:67-80.
4. Takizawa H, Tanaka M, Takami K, et al. Increased expression of transforminggrowth factor-b 1 in small airway epithelium from tobaccosmokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1476-1483.
5. Jeffery PK. Remodeling in asthma and chronic obstructive lungdisease. Am J Respir Crit Care Med 2001;164:S28-S38.
6. Chapman HA. Disorders of lung matrix remodeling. J Clin Invest2004;113:148-157.
7. Golec M. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. AnnAgric Environ Med 2007;14:1-4.
8. Matsushita I, Hasegawa K, Nakata K, et al. Genetic variants of human bdefensin-1 and chronic obstructive pulmonary disease. Bio chem Biophys Res Commun 2002;291:17-22.
9. Doss M, White MR, Tecle T, et al. Human defensins and LL-37 inmucosal immunity. J Leukoc Biol 2010;87:79-92.
10. Srensen O, Arnljots K, Cowland JB, et al. The human antibacterialcathelicidin, hCAP-18, is synthesized in myelocytes andmetamyelocytes and localized to specific granules in neutrophils.Blood 1997;90:2796-2803.
11. Bals R, Wang X, Zasloff M, et al. The peptide antibiotic LL-37/hCAP-18is expressed in epithelia of the human lung where it has broadantimicrobial activity at the airway surface. Proc Natl Acad Sci USA1998;95:9541-9546.
12. Frohm M, Agerberth B, Ahangari G, et al. The expression of the genecoding for the antibacterial peptide LL-37 is induced in humankeratinocytes during inflammatory disorders. J Biol Chem1997;272:15258-15263.
13. Hase K, Eckmann L, Leopard JD, et al. Cell differentiation is a keydeterminant of cathelicidin LL-37/human cationic antimicrobialprotein 18 expression by human colon epithelium. Infect Immun 2002;70:953-1063.
14. Ciornei CD, Sigurdardó ttir T, Schmidtchen A, et al. Antimicrobial andchemoattractant activity, lipopolysaccharide neutralization, cytotoxicity,and inhibition by serum of analogs of human cathelicidin LL-37.Antimicrob Agents Chemother 2005;49:2845-2850.
15. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic rolefor the human peptide antibiotic LL-37/hCAP-18. J Clin Invest2003;111:1665-1672.
16. Shaykhiev R, Bei-wenger C, Kändler K, et al. Human endogenousantibiotic LL-37 stimulates airway epithelial cell proliferation and woundclosure. Am J Physiol Lung Cell Mol Physiol 2005;289:L842-L848.
17. Golec M, Reichel C, Mackiewicz B, et al. Cathelicidin LL-37, granzymes,TGF-b1 and cytokines levels in induced sputum from farmers with andwithout COPD. Ann Agric Environ Med 2009;16:289-297.
18. Xiao W, Hsu YP, Ishizaka A, et al. Sputum cathelicidin, urokinaseplasminogen activation system components, and cytokines discriminatecystic fibrosis, COPD, and asthma inflammation. Chest 2005;128:2316-2326.
19. Golec M, Reichel C, Lemieszek M, et al. Cathelicidin LL-37 in bronchoalveolarlavage and epithelial lining fluids from COPD patients andhealthy individuals. J Biol Regul Homeost Agents 2012;26:617-625.
20. Jiang YY, Xiao W, Zhu MX, et al. The effect of human antibacterialpeptide LL-37 in the pathogenesis of chronic obstructive pulmonarydisease. Respir Med 2012;106:1680-1689.
21. Zhang YK, Jiang YY, Sun CC, et al. The human cathelicidin LL-37enhances airway mucus production in chronic obstructive pulmonarydisease. Biochem Biophys Res Commun 2014;443:103-109.
22. Park HJ, Cho DH, Kim HJ, et al. Collagen synthesis is suppressed indermal fibroblasts by the human antimicrobial peptide LL-37. J InvestDermatol 2009;129:843-850.
23. Vestbo J, Hurd SS, Agust?́ AG, et al. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med2013;187:347-365.
24. Cao Y, Zeng D, Song Q, et al. The effects of antisense interleukin-4gene transferred by recombinant adeno-associated virus vector on theairway remodeling in allergic rats. J Asthma 2010;47:951-958.
25. Jia XL, Li SY, Danq SS, et al. Increased expression of chondroitinsulphate proteoglycans in rat hepatocellular carcinoma tissues. World J Gastroenterol 2012;18:3962-3976.
26. Tsui L, Fong TH, Wang IJ. YC-1 targeting of hypoxia-inducible factor-1areduces RGC-5 cell viability and inhibits cell proliferation. Mol Vis2012;18:1594-1603.
27. Noguchi C, Umino T, Miyazaki Y, et al. TGF-b and glutathione promotetissue repair in cigarette smoke induced injury. J Med Dent Sci2007;54:109-116.
28. Aoudjehane L, Pissaia A, Scatton O, et al. Interleukin-4 induces theactivation and collagen production of cultured human intrahepaticfibroblasts via the STAT-6 pathway. Lab Invest 2008;88:973-985.
29. Kim TY, Lee HJ, Hwang KS, et al. Methylation of RUNX3 in various typesof human cancers and premalignant stages of gastric carcinoma. LabInvest 2004;84:479-484.
30. Bracke KR, D'hulst AI, Maes T, et al. Cigarette smoke-inducedpulmonary inflammation, but not airway remodelling, is attenuatedin chemokine receptor 5-deficient mice. Clin Exp Allergy 2007;37:1467-1479.
31. Aubert JD, Hayashi S, Hards J, et al. Platelet-derived growth factor andits receptor in lungs from patients with asthma and chronic airflowobstruction. Am J Physiol 1994;266:L655-L663.
32. Pierson T, Learmonth-Pierson S, Pinto D, et al. Cigarette smoke extractinducesdifferential expression levels of b-defensin peptides in humanalveolar epithelial cells. Tob Induc Dis 2013;11:10.
33. Semlali A, Witoled C, Alanazi M, et al. Whole cigarette smoke increasedthe expression of TLRs, HBDs, and proinflammory cytokines by humangingival epithelial cells through different signaling pathways. PLoSOne 2012;7:e52614.
34. Boxall C, Holgate ST, Davies DE. The contribution of transforminggrowth factor-b and epidermal growth factor signalling to airwayremodelling in chronic asthma. Eur Respir J 2006;27:208-229.
35. Korfhagen TR, Swantz RJ, Wert SE, et al. Respiratory epithelial cellexpression of human transforming growth factor-a induces lungfibrosis in transgenic mice. J Clin Invest 1994;93:1691-1699.
36. Oono T, Shirafuji Y, Huh WK, et al. Effects of human neutrophilpeptide-1 on the expression of interstitial collagenase and type Icollagen in human dermal fibroblasts. Arch Dermatol Res 2002;294:185-189.
37. Yoshioka S, Mukae H, Ishii H, et al. a-Defensin enhances expression ofHSP47 and collagen-1 in human lung fibroblasts. Life Sci 2007;80:1839-1845.
38. Scott MG, Davidson DJ, Gold MR, et al. The human antimicrobialpeptide LL-37 is a multifunctional modulator of innate immuneresponses. J Immunol 2002;169:3883-3891.
39. Yang D, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule-andepithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like1 (FPRL1) as a receptor to chemoattract human peripheral bloodneutrophils, monocytes, and T cells. J Exp Med 2000;192:1069-1074.
40. VanCompernolle SE, Clark KL, Rummel KA, et al. Expression andfunction of formyl peptide receptors on human fibroblast cells.J Immunol 2003;171:2050-2056.
41. He R, Shepard LW, Chen J, et al. Serum amyloid A is an endogenousligand that differentially induces IL-12 and IL-23. J Immunol 2006;177:4072-4079.
42. Sato M, Shegogue D, Gore EA, et al. Role of p38 MAPK in transforminggrowth factor b stimulation of collagen production by sclerodermaand healthy dermal fibroblasts. J Invest Dermatol 2002;118:704-711.
43. Kajanne R, Miettinen P, Mehlem A, et al. EGF-R regulates MMP functionin fibroblasts through MAPK and AP-1 pathways. J Cell Physiol2007;212:489-497.